Your session is about to expire
← Back to Search
Shock Wave Therapy
Post-Market Clinical Follow Up Study to Collect Additional Data and Imaging
N/A
Waitlist Available
Research Sponsored by Cynosure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days post treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing the ViaSure device, which uses shock waves to help heal tissues. Up to 50 participants will be involved across two locations. The study will check how well the device works and how tissues respond to the treatment. Participants may receive up to five treatments and will have follow-up visits for a few months after their last treatment. Shock wave therapy has been used in various medical treatments, including for rotator cuff disease and low back pain, but its efficacy and safety remain uncertain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 days post treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days post treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
# of Subjects With Altered Gene Expression
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Shockwave DeviceExperimental Treatment1 Intervention
The Shockwave device will be used on multiple areas of the body for the purpose of treating connective tissue.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Shockwave Treatment
2021
N/A
~10
Find a Location
Who is running the clinical trial?
Cynosure, Inc.Lead Sponsor
51 Previous Clinical Trials
1,231 Total Patients Enrolled
Jennifer CiviokStudy DirectorCynosure, Inc.
16 Previous Clinical Trials
487 Total Patients Enrolled